<DOC>
	<DOCNO>NCT02231788</DOCNO>
	<brief_summary>The Efficacy Fixed Dose Combination Telmisartan/S-Amlodipine 24-hour Ambulatory BP Control Compared Telmisartan Monotherapy</brief_summary>
	<brief_title>The Efficacy Combination Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy</brief_title>
	<detailed_description>A multicenter , Prospective , Randomized , Open-label , Phase 4 Trial design Evaluate Efficacy Fixed Dose Combination Telmisartan/S-Amlodipine 24-hour Ambulatory BP Control Compared Telmisartan Monotherapy</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . More 19 year hypertension patient 2 . Hypertension satisfy Clinic blood pressure measure time randomization Clinic MSSBP ≥ 140mmHg Clinic MSSBP ≥ 130mmHg diabetes mellitus chronic kidney disease Diabetes mellitus Before screening , diagnose diabetes mellitus treated oral hypoglycemic agent least 30 day OR Patients meet follow result laboratory test time randomization . : Fasting plasma glucose ≥ 126mg/dL Chronic kidney disease Patients meet follow result laboratory test time randomization . : 15mL/min/1.73m2 ≤ estimate glomerular filtration rate ≤ 60mL/min/1.73m2 3 . Patient decide participate sign informed consent form willingly 1 . Clinic MSSBP ≥ 200mmHg Clinic MSDBP ≥ 120mmHg time Screening Randomization 2 . As night worker sleep day whose work hour include 00:00 04:00 3 . Abnormal laboratory test result Aspartate aminotransferase/Alanine aminotransferase &gt; Upper normal limit X 3 Serum creatinine &gt; Upper normal limit X 4 4 . Secondary hypertension patient without diabetes mellitus , chronic kidney disease : coarctation aorta , cushing 's syndrome , pheochromocytoma , primary aldosteronism etc . 5 . Severe heart disease ( Heart failure ; New York Heart Association ( NYHA ) class 3 , 4 ) recent unstable angina myocardial infarction valvular heart disease arrhythmia require treatment within past 3 month 6 . Severe cerebrovascular disorder cerebral infarction , cerebral hemorrhage within 6 month 7 . Patient plan renal transplantation trial 8 . Severe malignant retinopathy 9 . Acute chronic inflammatory status require treatment 10 . A history cancer within five year 11 . A history angioedema ACE inhibitor angiotensinⅡ receptor blocker 12 . Severe hypersensitivity amlodipine telmisartan 13 . Surgical medical condition History major gastrointestinal surgery History active inflammatory bowel syndrome within 12 month Abnormal pancreatic function Gastrointestinal/rectal bleed Urinary tract obstruction 14 . Need antihypertensive drug trial 15 . Need prohibited medication specify protocol 16 . Administration Investigational Product within 30 day 17 . History drug alcohol abuse within 6 month 18 . Pregnant , breastfeed childbearing age n't use adequate contraception 19 . Another clinical condition investigator 's judgement</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Telminuvo</keyword>
	<keyword>Telmitrend</keyword>
	<keyword>Hypertension</keyword>
	<keyword>24hr ABPM</keyword>
	<keyword>Telmisartan</keyword>
	<keyword>S-amlodipine</keyword>
</DOC>